MDPediatric Congenital Hematologic Disorders Center, Shahid Beheshti University of Medical Sciences, Tehran, IranTehran, Tehran, Iran
OC 50.3 - Inhibitor development upon switch after 50 EDs from plasma-derived to recombinant FVIII in PUPs with severe haemophilia A: the PUP-SWITCH study results
Tuesday, June 27, 202311:15 – 11:30 ET